John Miller
Family Medicine · New Castle, INNPI 1386726248
Payments from drug & device makers
Across 331 payments — averaging $17.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$826
- AbbVie$710
- Lilly USA, LLC$700
- Pfizer$418
- Biohaven Pharmaceuticals, Inc.$306
- Amgen$253
- plus $3K from 34 others
What the payments were for
- Food & beverage$5,744100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVENITY$139
- NURTEC ODT$115
- XIFAXAN$107
- ELIQUIS$102
How this compares
$5,744 in reported general payments places this provider in the 85th percentile of 2,709 family medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 171 | $110,588 |
| TrulicityDulaglutide | 54 | $73,120 |
| RybelsusSemaglutide | 49 | $67,088 |
| JanuviaSitagliptin Phosphate | 69 | $66,597 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 61 | $54,751 |
| OzempicSemaglutide | 21 | $33,735 |
| MyrbetriqMirabegron | 82 | $33,276 |
| XareltoRivaroxaban | 33 | $28,891 |
| MounjaroTirzepatide | 17 | $25,376 |
| JardianceEmpagliflozin | 30 | $24,220 |
| Spiriva RespimatTiotropium Bromide | 34 | $18,611 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 744 | $16,583 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 132 | $15,762 |
| LinzessLinaclotide | 16 | $15,486 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 22 | $14,855 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Abrysvo | $418 | $115,899188 claims |
| Novo NordiskRybelsus, Ozempic | $826 | $100,82370 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $700 | $98,49671 claims |
| GSKTrelegy Ellipta, Incruse Ellipta, Breo Ellipta | $101 | $69,64996 claims |
| MerckJanuvia | $33 | $66,59769 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta | $70 | $50,85178 claims |
| Astellas Pharma US IncMyrbetriq | $125 | $33,27682 claims |
| Johnson & JohnsonXarelto | $46 | $28,89133 claims |
| AbbVieLinzess | $710 | $15,48616 claims |
| BayerKerendia | $96 | $11,32614 claims |
| AstraZenecaBrilinta | $186 | $5,62915 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,709 family medicine providers in Indiana.
Other family medicine in New Castle
- Blair BrengleIndianapolis$10.6M
- Laura HelmanMishawaka$4M
- J Christopher SartoreEvansville$3.9M
- Hubert ReyesEvansville$3.2M
- David SchultzEvansville$3M
- Steven SmithIndianapolis$2.5M
- Renee Michelle GalenNewburgh$2.1M
- Eric HewittAvon$1.7M
- Alexander Dela LlanaEvansville$1.6M
- Jonathan ConditMuncie$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.